He, Leicheng. 2023. “SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits”. Highlights in Science, Engineering and Technology 74 (December): 1717-22. https://doi.org/10.54097/m9vm2798.